CIK 0001528172 · Non-accelerated filer<br>Smaller reporting company
ENDONOVO THERAPEUTICS, INC.
Sign in to watch- Ticker
- ENDV
- Exchange
- OTC
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452552528
- Phone
- (800) 489-4774
- Business address
- 6320 CANOGA AVENUE, 15TH FLOOR, WOODLAND HILLS, CA, 91367
- Former names
- Hanover Portfolio Acquisitions, Inc.
- 4 Open-market buy President bought 8,200 shares at an average $0.03 ($283)
- 4 Open-market buy President bought 18,009 shares at an average $0.03 ($628)
- 4 Open-market buy President bought 8,000 shares at an average $0.04 ($288)
- 4 Open-market buy President bought 6,000 shares at an average $0.04 ($211)
- 4 Open-market buy President bought 5,000 shares at an average $0.04 ($182)
- 4 Open-market buy President bought 8,000 shares at an average $0.04 ($300)
- 4 Open-market buy President bought 8,000 shares at an average $0.04 ($306)
- 4 Open-market buy President bought 4,000 shares at an average $0.04 ($148)
- 4 Open-market buy President bought 13,200 shares at an average $0.04 ($509)
- 4 Open-market buy President bought 5,100 shares at an average $0.04 ($195)
- 4 Open-market buy President bought 24,100 shares at an average $0.05 ($1,094)
- 4 Open-market buy President bought 26,000 shares at an average $0.06 ($1,430)
- 4 Open-market buy President bought 28,400 shares at an average $0.05 ($1,350)
- 10-Q Report Quarterly Report
- 4 Open-market buy President bought 24,100 shares at an average $0.04 ($960)
- NT 10-Q Other NT 10-Q
- 4 Open-market buy President bought 7,100 shares at an average $0.03 ($243)
- 4 Open-market buy President bought 18,300 shares at an average $0.03 ($602)
- 4 Open-market buy President bought 22,200 shares at an average $0.03 ($745)
- 4 Open-market buy President bought 20,000 shares at an average $0.04 ($747)
Page 11 of 26 · 502 filings